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ABSTRACT 
A Study of Osteocyte Apoptosis by Region and Quadrant in Murine Cortical Bone  
Jessica Kristen Chan 
Osteocytes undergo apoptosis to spatially and temporally initiate bone remodeling.  This 
study investigates the distribution of apoptotic osteocytes within different quadrants and 
regions of cortical bone and compares the frequency of osteocyte apoptosis to regional factors 
associated with bone remodeling.  Specifically, the quantity of apoptosis was compared to 
levels of the bone morphagenic protein antagonists noggin and gremlin.  Samples of unloaded 
right tibial bone obtained from C57/Bl/6 mice underwent TUNEL staining for apoptotic 
osteocytes and were counterstained with methyl green to detect osteocyte viability.  Cross 
sectional areas of bone were divided into four quadrants (cranial, caudal, medial, and lateral) 
and three regions (proximal, midshaft, and distal) for analysis.  Densities and percentages of 
osteocytes were measured within each area.  While the results show that there were no 
differences among quadrants, regional variations were found in osteocyte apoptosis.  A 
significantly higher density of apoptotic osteocytes was found in the midshaft region which also 
displayed higher levels of BMP antagonists.  Using regression analysis, a positive linear 
relationship between apoptotic osteocytes and gremlin was established while noggin showed a 
negative linear correlation for the percentage of apoptotic osteocytes.  Further studies are 
needed to observe the distribution of apoptotic osteocytes within loaded bone to confirm the 
exact relationship between osteocyte apoptosis and bone remodeling. 
 
Keywords: osteocyte apoptosis, bone remodeling 
v 
 
ACKNOWLEDGEMENTS 
 
I would like to thank Dr. Scott Hazelwood for the opportunity to work on this project.  
Thank you for your patience, guidance, and generosity throughout the entire process.  I want to 
thank my committee members, Dr. Dan Wash and Dr. Lanny Griffin.  I would also like to thank 
Scott Mosher for spending hours in the lab working side by side on our projects.  I would also 
like to thank all the professors that contributed to my research.  Thank you Dr. Lily Laiho for the 
training and use of your microscope, Dr. Kristen Cardinal for all the lab assistance and 
microtome training, and Dr. Trevor Cardinal for help with preparing, processing, and providing 
the subjects.  Finally, I would like to thank my parents. 
 
This project was supported by NIH Grant AR51555. 
  
vi 
 
 
TABLE OF CONTENTS 
 
LIST OF TABLES ............................................................................................................................................ vii 
LIST OF FIGURES ........................................................................................................................................... ix 
I. INTRODUCTION .......................................................................................................................................... 1 
1.1 Bone Biology ....................................................................................................................................... 1 
1.2 Bone Remodeling ................................................................................................................................ 5 
1.3 The Osteocyte ..................................................................................................................................... 9 
1.4 Osteocyte Apoptosis ......................................................................................................................... 13 
1.5 Study Goals ....................................................................................................................................... 18 
II. MATERIALS AND METHODS .................................................................................................................... 19 
2.1 Sacrifice ............................................................................................................................................. 19 
2.2 Specimen Preparation and Processing.............................................................................................. 20 
2.3 TUNEL staining and Osteocyte Apoptosis ......................................................................................... 20 
2.4 Image Capture, Processing, and Analysis .......................................................................................... 22 
2.5 Statistical Analysis ............................................................................................................................. 24 
2.6 BMU Identification ............................................................................................................................ 25 
III. RESULTS .................................................................................................................................................. 25 
3.1 Osteocyte Densities .......................................................................................................................... 26 
3.2 Regression Analysis ........................................................................................................................... 32 
3.3 BMU Analysis .................................................................................................................................... 39 
IV. DISCUSSION ........................................................................................................................................... 40 
Limitations .............................................................................................................................................. 47 
Applications and Future Work ................................................................................................................ 49 
Conclusion ............................................................................................................................................... 51 
REFERENCES ................................................................................................................................................ 52 
Appendix A .................................................................................................................................................. 56 
 
  
 
 
vii 
 
LIST OF TABLES 
 
Table11.  Apoptotic osteocyte density, viable osteocyte density, total lacunar density, percentage of 
apoptotic osteocytes, and percentage of viable osteocytes by individual subjects.  Standard deviations in 
parentheses. ............................................................................................................................................... 26 
 
Table22.  Quadrantal diferences of apoptotic osteocyte density, viable osteocyte density, total lacunar 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes across all subjects.  
Standard deviations in parentheses. .......................................................................................................... 27 
 
Table32a.  Mean quadrantal data gathered from the proximal region for apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of 
viable osteocytes across all subjects.  Standard deviations in parentheses. .............................................. 28 
 
Table42b.    Mean quadrantal data gathered from the midshaft region for apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of 
viable osteocytes across all subjects.  Standard deviations in parentheses. .............................................. 28 
 
Table52c. Mean quadrantal data gathered from the distal region for apoptotic osteocyte density, viable 
osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of viable 
osteocytes across all subjects.  Standard deviations in parentheses. ........................................................ 29 
 
Table63. Regional differences of apoptotic osteocyte density, viable osteocyte density, total lacunar 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes across all subjects.  
Standard deviations in parentheses. .......................................................................................................... 30 
 
Table73a. Mean regional data gathered from the cranial quadrant for apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of 
viable osteocytes across all subjects.  Standard deviations in parentheses. .............................................. 30 
 
Table83b. Mean regional data gathered from the caudal quadrant for apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of 
viable osteocytes across all subjects.  Standard deviations in parentheses. .............................................. 31 
 
Table93c. Mean regional data gathered from the medial quadrant for apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of 
viable osteocytes across all subjects.  Standard deviations in parentheses. .............................................. 31 
 
Table03d. Mean regional data gathered from the lateral quadrant for apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of 
viable osteocytes across all subjects.  Standard deviations in parentheses. .............................................. 32 
 
Table14. BMP antagonist levels. ................................................................................................................. 33 
 
Table25. Linear relationships between BMP antagonist expression and apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of 
viable osteocytes. ....................................................................................................................................... 33 
 
viii 
 
Table36.  Number of BMUs identified across all subjects .......................................................................... 39 
  
  
ix 
 
 LIST OF FIGURES 
 
Figure 1.  Cortical and trabecular bone structure ......................................................................................... 2 
 
Figure 2.  The structure of a Basic Multicellular Unit (BMU). ....................................................................... 5 
 
Figure 3.  The bone remodeling cycle. .......................................................................................................... 7 
 
Figure 4.  Osteocyte network.  Osteocyte lacunae (A) are connected via canaliculi (B) allowing 
communication.  A Haversian space resides in middle (C). ........................................................................ 10 
 
Figure 5.  Mechanotransduction in bone. ................................................................................................... 11 
 
Figure 6.  The difference between apoptotic and necrotic cells. ............................................................... 14 
 
Figure 7.  Cross sectional views of murine right tibia (A) TUNEL stained sections. (B) Methyl green  
stained sections.  Cr=cranial, Ca=caudal, M=medial, L=lateral.  To the right is an image of a right tibia  
and fibula divided regionally. ...................................................................................................................... 22 
 
Figure 8.  TUNEL stained image. ................................................................................................................. 23 
 
Figure 9. Methyl green stained image. ....................................................................................................... 24 
 
Figure 10.  BMU within murine cortical bone. ............................................................................................ 25 
 
Figure 11. Regression analysis of BMP expression versus apoptotic osteocyte density.  Data from 
proximal region is represented with the diamond (♦) symbol, midshaft region is represented with the 
circle (●) symbol, and distal region is represented with the triangle (▲) symbol.  Cranial, caudal, medial, 
and lateral points are colored blue, red, green, and yellow respectively.  All points indicating noggin 
levels are solid shapes, while all points indicating gremlin levels are shape outlines. .............................. 34 
 
Figure 12. Regression analysis of BMP expression versus percentage of apoptotic osteocytes. Data from 
proximal region is represented with the diamond (♦) symbol, midshaft region is represented with the 
circle (●) symbol, and distal region is represented with the triangle (▲) symbol.  Cranial, caudal, medial, 
and lateral points are colored blue, red, green, and yellow respectively.  All points indicating noggin 
levels are solid shapes, while all points indicating gremlin levels are shape outlines. .............................. 35 
 
Figure 13.  Regression analysis of BMP expression versus total lacunar density. Data from proximal 
region is represented with the diamond (♦) symbol, midshaft region is represented with the circle (●) 
symbol, and distal region is represented with the triangle (▲) symbol.  Cranial, caudal, medial, and 
lateral points are colored blue, red, green, and yellow respectively.  All points indicating noggin levels 
are solid shapes, while all points indicating gremlin levels are shape outlines. ......................................... 36 
 
Figure 14.  Regression analysis of BMP expression versus viable osteocyte density. Data from proximal 
region is represented with the diamond (♦) symbol, midshaft region is represented with the circle (●) 
symbol, and distal region is represented with the triangle (▲) symbol.  Cranial, caudal, medial, and 
x 
 
lateral points are colored blue, red, green, and yellow respectively.  All points indicating noggin levels 
are solid shapes, while all points indicating gremlin levels are shape outlines. ......................................... 37 
 
Figure 15. Regression analysis of BMP expression versus percentage of viable osteocytes. Data from 
proximal region is represented with the diamond (♦) symbol, midshaft region is represented with the 
circle (●) symbol, and distal region is represented with the triangle (▲) symbol.  Cranial, caudal, medial, 
and lateral points are colored blue, red, green, and yellow respectively.  All points indicating noggin 
levels are solid shapes, while all points indicating gremlin levels are shape outlines. .............................. 38 
 
  
1 
 
I. INTRODUCTION 
1.1 Bone Biology 
 
Bone Function and Properties 
 Bone is a complex and dynamic tissue essential in the maintenance of the human body.  
Its main functions include locomotion, support of organs, protection, attachment sites for 
muscles, mineral homeostasis, and blood cell formation (Marieb 2005).  As the load bearing 
structure of the body, bone must be stiff enough to resist deformation, flexible enough to 
absorb energy from loading, and light enough to allow mobility (Bilezikian 2008).  These 
properties are achieved through its unique structure and composition. 
Bone Structure 
The external surface of bone is covered by the periosteum, a double layered membrane.  
The outer fibrous layer serves as an insertion point for ligaments and tendons while its inner 
osteogenic layer is more cellular and vascular.  Perforating fibers secure the periosteum to 
inner bone matrix.  Beneath the periosteum a combination of dense cortical bone and porous 
trabecular bone constitute the main bone matrix.  Most internally, a delicate inner membrane, 
the endosteum, lines the trabecular bone and canals within the cortical bone (Marieb 2005).   
Cortical or compact bone has porosities ranging from 5 to 10 percent.  It is found 
surrounding the marrow cavity and forms the shafts of long bones.  This stiffer bone responds 
slowly to changes in loads and shifts accordingly.   The main structural unit of cortical bone is 
the osteon.  Concentric rings of lamella or matrix tubules form osteons.  They are cylindrical in 
shape and arranged parallel to the long axis of bone, giving bone the ability to withstand 
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torsion and bending stresses.  The center of each osteon contains a Haversian canal which 
consists of small blood vessels and nerves.   Haversian canals are connected by short transverse 
Volkmann’s canals, containing blood vessels that also connect to the outside surfaces of bone.  
Compact bone also contains temporary resorption cavities created by osteoclasts during the 
initial phases of remodeling (Figure 1).   
Trabecular, also known as cancellous or spongy bone, is extremely light and porous with 
porosities between 75 to 95 percent.  It consists of trabeculae, plates or struts that are 
randomly arranged in a sponge-like three dimensional matrix.   This provides resilience and 
shock absorption in areas such as the epiphyseal region of long bones.  Due to its large surface 
area and many voids, trabecular bone partakes in metabolic functions.  
 
Figure 1.  Cortical and trabecular bone structure (www.iofbonehealth.org, 2007) 
Bone Matrix 
Bone is composed of an extracellular and cellular component.  The extracellular makeup 
accounts for about 90% of its volume while the cells and blood vessels make up the remaining 
10%. 
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The extracellular matrix includes an inorganic phase responsible for about two thirds of 
its weight and an organic phase that comprises the remaining one third.   The inorganic matrix 
or mineral phase is made up of hydroxyapatite crystals, tightly packed mineral salts that are 
responsible for bones hardness and resistance to compression.  The organic phase primarily 
consists of type I collagen and noncollagenous proteins.   This phase is also known as osteoid 
and plays an important part in bones flexibility and tensile strength, allowing it to stretch and 
twist (Marieb 2005). 
Bone Cells 
The cellular component of bone includes osteoclasts, osteoblasts, osteocytes, and bone 
lining cells.  They can be categorized into two main cell types, bone resorbing cells or bone 
forming cells.    
Osteoclasts are large multinuclear cells that resorb bone.  They are formed by the fusion 
of monocytes that originate from hematopoietic stem cells within the bone marrow.  Generally 
located on the surface of bone, osteoclasts are very mobile, resorbing at a rate of 10 microns 
per day.  They are distinguished by their characteristic ruffled border where enzymes are 
secreted to help break down proteins. 
Osteoblasts are mononuclear cuboidal cells that form new bone.  They are derived from 
mesenchymal cells located in the bone marrow.  Their formation is believed to be triggered by 
mechanical stress on bone (Martin, Burr et al. 1998).  Osteoblasts produce osteoid, the organic 
portion of the bone matrix, at a rate of 1 micron per day.   
Osteocytes are former osteoblasts buried within the bone matrix.  They sit in cavities 
called lacunae and communicate with each other through tiny tunnels known as canaliculi.  
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Processes from adjoining cells are connected through gap junctions and maintain the signals for 
cell to cell communication.  These pathways allow for communication between cells as well as 
within cells to maintain the bone matrix.  Making up more than 90% of bone cells, osteocytes 
are the most abundant cell type yet their function is the least understood.   They are thought to 
play an important role in the signaling mechanism responsible for bone remodeling because of 
their ideal location and high numbers within the bone matrix.   
Once osteoblasts become inactive and old, they form bone lining cells.  They are thin 
elongated cells that appear flattened, covering the surface of bone.  Bone lining cells maintain 
communication through gap junctions and are thought to play a similar role as osteocytes in 
terms of sensing mechanical strain and monitoring mineral transfer.  They are also believed to 
initiate a bone remodeling response (Martin, Burr et al. 1998).  Rodan proposed a theory 
suggesting bone lining cells as the controller of bone remodeling (Rodan 1992).  Their ideal 
anatomic location allows them to transmit signals that initiate new BMU’s.  Bone lining cells 
possess receptors for parathyroid hormone and vitamin D and their response to certain 
activation signals is consistent with the appearance of osteoclasts.  This provides a way for 
osteoclasts to indirectly respond to hormonal and physical signals interpreted by bone lining 
cells (Martin, Burr et al. 1998). 
5 
 
 
Figure 2.  The structure of a Basic Multicellular Unit (BMU).  The upper half is a longitudinal 
section through an active BMU while the lower half is an image depicting the positioning of 
the bone cells.  The blue osteoclasts can be seen on the leading edge while the green 
osteoblasts follow (Robling, Castillo et al. 2006). 
1.2 Bone Remodeling 
 
Modeling vs. Remodeling 
 Forty years ago two processes were discovered responsible for the sculpting and 
shaping of bone, modeling and remodeling.   Modeling occurs during growth and results in 
changes in bone size and shape.   Bone is resorbed in some places and deposited at others, but 
never at the same location.  Once the adult skeleton has matured, modeling is severely 
reduced.  Throughout a lifetime, bone strength is maintained by remodeling which removes 
damaged bone as a consequence of fatigue or varying load conditions.  Remodeling’s unique 
coupling mechanism involves bone first being resorbed and then deposited in the same 
location, resulting in little change of bone mass. This process is responsible for replacement of 
the skeleton every ten years (Manolagas 2000).    
Process 
Bone remodeling involves a group of cells that work together three dimensionally to 
form a basic multicellular unit (BMU) (Figure 2).  They can be found on the inner surface of 
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bone, specifically intracortical and trabecular bone (Jilka 2003).  In cortical bone, BMU’s tunnel 
through with a team of approximately 10 osteoclasts in front followed by hundreds of 
osteoblasts in the rear.  A vascular capillary, nerve supply, and connective tissue are also part of 
the middle of the BMU (Manolagas 2000). Bone remodeling is activated by a chemical or 
mechanical signal that causes osteoclasts to form from precursor cells.  Osteoclasts remove 
bone at rate of 40 microns/ day creating a resorption space at a targeted area.  Once 
osteoclasts have finished eroding, they disappear, allowing osteoblasts to take over.  The 
transition from osteoclast activity to osteoblast activity is approximately a 10 day period known 
as the reversal phase.   This phase can be identified by the cement line which marks the 
beginning of bone formation, separating new osteons from older ones.  Osteoblasts assemble 
on the bottom of the resorption space and deposit layers of new bone known as osteoid or 
unmineralized bone matrix.   The mineralization of osteoid lasts about 3 months where mineral 
is deposited within the collagen fibers.  Once deposition finishes, an empty space is left in the 
middle for the Haversian canal which helps deliver nutrients to the BMU during formation of 
the new osteon.    The final stage of remodeling is known as quiescence or resting (Figure 3).  
Osteoblasts either become osteocytes embedded in the bone matrix or flatten out into bone 
lining cells.  This new unit formed is called a secondary osteon (Martin, Burr et al. 1998).   
Individual BMU’s have a total lifespan of about 6-9 months.   Bone remodeling in trabecular 
bone follows the same sequence of events as in cortical bone but travels across bone in a 
slightly different manner.  Rather than tunneling through bone, cells remove and replace 
trench-like packets of bone along the surface of the trabeculae (Manolagas 2000). 
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Figure 3.  The bone remodeling cycle (Hill 1998). 
Purpose 
 
Bone is dynamic and responds to strains placed on it.  Frost’s mechanostat theory 
describes the mechanical adaption of the skeleton in relation to strain magnitudes.  This theory 
is based on the idea that bone maintains a physiologic range of strain values.   Any deviation 
from this range generates an adaptive response that aims to return bone to its physiologic 
value.  When strains exceed this range due to loading, bone remodeling is inhibited, resulting in 
bone formation.  Similarly, when strains drop due to a decrease in loading bone remodeling is 
increased, resulting in bone loss (Martin, Burr et al. 1998).   
The concept that bone adapts to its surrounding mechanical environment was made 
popular by Julius Wolff.   Mechanical loading strongly influences bone remodeling.  Disuse or 
lack of loading, most common in bedridden individuals, accelerates bone resorption leading to 
a loss of bone mass.  Fatigue damage typically caused by overuse can also stimulate 
remodeling.  Bone remodeling serves the main purpose of replacing and repairing damaged 
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bone tissue.  Disuse and damage are two mechanical factors responsible for the activation of 
bone remodeling (Robling, Castillo et al. 2006). 
Fatigue Microdamage 
  Fatigue, creep, and other similar mechanical processes can permanently alter the 
microstructure of bone when loaded (Martin 2003).  Every day activities subject bone to 
repetitive loading which initiates microcracks, first observed by Frost, within the mineralized 
bone matrix.  The accumulation of microdamage is undesirable because it can lead to stress 
fractures, increased bone fragility, and overall degeneration of bone health.  However, bone is 
unique in its ability to remove microdamage through bone remodeling.  
Since microdamage can only be removed through remodeling, it has been proposed that 
microcracks initiate bone remodeling.  Osteonal remodeling increased when bones were 
impulsively and repetitively loaded suggesting bone remodeling was initiated by loads (Burr, 
Martin et al. 1985).  Fatigue loading within physiologic strains increased microdamage (Burr, 
Martin et al. 1985).  Experimental studies in canine bones that were cyclically loaded to create 
damage showed that resorption spaces were more likely to be associated with microcracks 
than by chance (Mori 1993).  However, it still remained unclear whether the cracks 
accumulated at preexisting resorption spaces or if they actually initiated new remodeling.  Burr 
and Mori further demonstrated in canine bone that cracks caused the resorption spaces, 
verifying that remodeling followed fatigue damage, removing and replacing it (Mori 1993).  A 
more recent study on adult rat ulna, which unlike canine bone does not characteristically 
Haversian remodel, showed that fatigue loading activated intracortical remodeling.  This was 
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significant because damage-activated remodeling was introduced in a species that does not 
typically remodel their bone (Bentolila, Boyce et al. 1998).   
While it has been established the remodeling is a mechanism for dealing with fatigue 
damage, exactly how cells are targeted for remodeling remains poorly understood.  Much 
research has focused on the osteocyte as an important bone cell in the signaling pathway 
guiding bone turnover. 
1.3 The Osteocyte  
 
Mechanosensors 
Osteocytes are the most abundant, longest lived, and least understood cell type 
compared to osteoblasts and osteoclasts.  They are regularly spaced throughout the 
mineralized bone matrix in cave-like lacunae.  Lacunae are connected via long slender 
processes known as canaliculi (Figure 4).  These processes connect osteocytes with each other 
and bone lining cells, allowing for communication throughout the entire bone matrix (Bonewald 
2006).   Intercellular contacts known as gap junctions allow for communication with other cell 
types (Doty 1981).  However, immediately surrounding the osteocyte the matrix does not 
calcify, forming a three dimensional network of lacunae and canaliculi, important in the 
detection of mechanical strain (Burger and Klein-Nulend 1999).  Because of their large 
numbers, distribution through the matrix, and high degree of interconnectivity, osteocytes are 
thought to be the main cell regulating bone mass and structure biochemically through strain 
(Lanyon 1993).  As a result, they play a pivotal role in bone remodeling. 
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Figure 4.  Osteocyte network.  Osteocyte lacunae (A) are connected via canaliculi (B) allowing 
communication.  A Haversian space resides in middle (C) (Martin, Burr et al. 1998). 
Bone responds to mechanical loading by mechanotransduction, a process in which a 
physical force is converted into a signal that elicits a cellular response (Robling, Castillo et al. 
2006).  Within the bone matrix, osteocytes act as strain receptors and transducers, adopting 
the role of mechanosensors (Marotti 1996).  
Mechanical Simulation 
How mechanical loading is sensed by osteocytes remains somewhat of a mystery.  
Mechanical loading, stress, causes a small deformation of the calcified matrix, strain.  The 
osteocyte network with its lacuna-canalicular porosity is thought to be the site of 
mechanosensing in bone tissue (Figure 5).  When force is applied to bone, it elicits several 
potential cellular stimuli.  Originally, osteocytes were thought to respond directly to the 
mechanical deformation of the bone matrix.  However, it is more likely that fluid flow of 
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canalicular interstitial fluid is the stress derived factor that informs osteocytes about the level 
of bone loading (Skerry, Bitensky et al. 1989; Cowin, Moss-Salentijn et al. 1991). 
 
Figure 5.  Mechanotransduction in bone (Klein-Nulend, Semeins et al. 1995). 
 
In order to sense mechanical strain, osteocytes must respond to mechanical loading 
applied to bone.  An in vivo study intermittently loading  turkey ulnae showed an increase in 
the number of osteocytes expressing glucose-6-phosphate dehydrogenase (G6PD), a marker of 
cell metabolism with increased strain (Skerry, Bitensky et al. 1989).  Strain magnitude varied 
between .05 and 2% similar to local strains found in bone as a result of physiological loads.  
Intermittent loading at physiological strain magnitude activated strain related changes of 
metabolic processes in osteocytes.  In vivo experiments demonstrated osteocytes produce high 
levels of intracellular messengers such as NO and prostaglandins in response to pulsating fluid 
flow and are the most responsive bone cell to fluid flow (Klein-Nulend, Semeins et al. 1995). 
The generation of these potential signaling molecules indicates that osteocytes may function as 
mechanosensors of local strain in bone. 
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In various animals that were physiologically loaded, Rubin found maximal strains of 
0.2%-0.3% (Rubin 1984).  However, in vitro studies of isolated stretched bone cells showed they 
were sensitive to strains between 0.7% and 10% (Murray and Rushton 1990).  Interestingly, 
intact bone tissue was sensitive to lower strain levels in comparison to individual bone cells 
which required higher strains to elicit a cellular response.  Local strains at the cellular level were 
higher than overall strains of the entire whole bone because whole bone is stiff due to the 
mineralization of the extracellular matrix (Rubin 1984).  It is that local force derived from the 
bulk strain of the whole bone that activates osteocytes.   Smaller matrix strains are amplified 
into larger signals detected by osteocytes.  Therefore, it was proposed that the strain derived 
interstitial fluid flow through the lacunocanalicular network was directly related to the amount 
of strain of the bone (Cowin, Moss-Salentijn et al. 1991).  
The mechanism that detects strain within bone may be the flow of interstitial fluid 
which stimulates the cell (Cowin, Moss-Salentijn et al. 1991).  Streaming potentials and 
chemotransport were two possible stimuli in the activation of bone cells, but Bakker proved 
that shear stress was the flow-derived mechanism (Bakker, Soejima et al. 2001).  When bone is 
loaded, interstitial fluid is squeezed through the nonmineralized matrix surrounding osteocytes 
towards the Haversian canal.  Fluid flow causes a shear stress on osteocytes’ cell membrane 
that deforms the cells within their lacunae and the dendrites within their canaliculi (Weinbaum, 
Cowin et al. 1994). 
While osteocytes are sensitive to fluid shear stress, their viability may be dependent on 
nitric oxide (NO) production that varies with strain.  The tip of the cutting cone of a BMU is a 
predicted area of low canalicular flow resulting in low NO production, causing osteocytes to 
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enter apoptosis (Burger, Klein-Nulend et al. 2003).  Basal levels of NO under adequate fluid flow 
prevent apoptosis and promote the survival of osteocytes.  Other auto paracrine signaling 
molecules such as prostaglandins may be involved in osteocyte viability.  Mechanically stressed 
chicken osteocytes generated an increase in prostaglandin E2 production which is known to 
also inhibit apoptosis (Ajubi, Klein-Nulend et al. 1996).  The factors responsible for triggering 
decreased osteocyte viability or apoptosis are affected by mechanical loading in bone.   
1.4 Osteocyte Apoptosis 
 
Osteocytes can undergo apoptotic cell death in tissue undergoing rapid remodeling 
(Noble 2003). Recently, there has been a growing interest in apoptotic osteocytes as part of the 
signaling mechanism responsible for spatially initiating bone remodeling. 
Osteoclasts and osteoblasts undergo apoptosis, or programmed cell death (Steller 
1995).  Apoptosis refers to a form of cell suicide or programmed cell death characterized by 
specific morphological changes (Figure 6).  These include cytoplasmic shrinkage, nuclear 
chromatin condensation, DNA degradation, and cytoplasmic blebbing.  Cells lose contact with 
neighboring cells and fragment into apoptotic bodies that are phagocytosed by surrounding 
cells without generating an inflammatory response.  This is not to be confused with another 
type of cell death, necrosis.  This is characterized by cell swelling, chromatin flocculation, loss of 
membrane integrity, and a general local inflammatory response.  This controlled deletion of 
cells plays an opposing role to mitosis in regulating cell populations (Kerr, Wyllie et al. 1972).   
Apoptosis plays a key role in development and homeostasis of the skeleton.  Recent studies 
have focused on the role of apoptotic osteocytes as a possible therapeutic target in the 
prevention of bone loss. 
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Figure 6.  The difference between apoptotic and necrotic cells (Gewies 2003). 
Osteocyte apoptosis is regulated by mechanical strain.  It has been shown that 
physiological levels of strain by stretching or pulsatile fluid flow prevent apoptosis of cultured 
osteocytes (Bakker, Klein-Nulend et al. 2004; Plotkin, Mathov et al. 2005).  There appears to be 
a U shaped relationship between mechanical strain and osteocyte survival.  In regions of 
physiological levels of strain in rat ulna, the number of apoptotic osteoctyes remained low 
suggesting that nondamaging strain promotes osteocyte viability.  Low levels of strain and 
damagingly high levels of strain induced apoptosis and subsequent remodeling (Noble, Peet et 
al. 2003).  Similarly, reduced mechanical forces induced by unloading increased the number of 
apoptotic osteocytes in vivo (Aguirre, Plotkin et al. 2006).   In rat hindlimbs, unloading increased 
the percentage of apoptotic osteocytes which were associated with osteoclastic bone 
resorption (Basso and Heersche 2006).  Mechanical strain stimulates osteocytes to evoke some 
sort of response in remodeling.  Specifically the apoptosis of osteocytes may be important in 
the targeting mechanism that drives bone adaptation. 
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Apoptosis and Bone Remodeling 
 
Apoptosis disrupts the osteocyte network that leads to bone remodeling.   Apoptotic 
osteocytes have been associated with high rates of bone turnover (Noble, Stevens et al. 1997).  
In areas of growing bone, apoptotic osteocytes were present in a nonuniform distribution 
suggesting a relationship between osteoclastic resorption and programmed cell death.  
Osteocyte apoptosis in developing bone was observed in places where intense bone resorption 
took place (Bronckers, Goei et al. 1996).  Estrogen withdrawal in rats and glucocorticoid 
treatment induced osteocyte apoptosis which is associated with high rates of bone turnover 
(Tomkinson, Gevers et al. 1998; Weinstein, Nicholas et al. 2000).  Both lead to deleterious 
effects on bone which may be caused by the disruption of the osteocyte canalicular network.  
Microdamage can alter the osteocytes normal environment in a way that induces apoptosis.  A 
model of the lacunocanalicular network was developed to simulate the effects of interstitial 
fluid flow after fatigue loading.  This model demonstrated that microcracks caused by 
overloading altered fluid flow by decreasing the transport of signaling molecules to osteocytes 
and thereby disrupted the network (Tami, Nasser et al. 2002). 
Osteocyte apoptosis follows load induced microdamage.   Verborgt showed that dying 
osteocytes appeared after fatigue induced bone microdamage in rats (Verborgt, Gibson et al. 
2000).  Apoptotic osteocytes were not widespread but rather localized to areas containing 
microcracks.  These areas were later found to be the site of osteoclastic resorption.   
Furthermore in additional fatigue loaded rats evidence of the proapoptotic gene product Bax 
were found adjacent to sites of microdamage where bone resorption occurs.  In contrast, the 
anti apoptotic gene product Bcl-2 was expressed at some distance from the microcracks 
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(Verborgt, Tatton et al. 2002).  By expressing these gene products, osteocytes demonstrate the 
capability to protect themselves from apoptosis.   They appear to exercise some level of control 
in the regulation and directing of resorption associated with microdamage and apoptosis. 
Temporal and Spatial Relationship 
 
Apoptotic osteocytes are not randomly distributed within the bone matrix but are 
generally found in the vicinity of resorption areas. In chicken radii, osteocyte apoptosis 
increased following osteotomy and was followed by the appearance of osteoclasts (Clark, Smith 
et al. 2005).  The temporal relationship between osteocyte apoptosis and intracortical 
osteoclast appearance supports the theory that osteocyte apoptosis plays an important role in 
the bone remodeling process.   Also, Aguirre showed that osteocyte apoptosis preceded 
recruitment of osteoclasts to areas of unloading and subsequent bone loss.  After three days of 
tail suspension, apoptotic osteocytes prevailed around endosteal regions of cortical bone 
where resorption occurred by day 18.  In contrast, the control ambulatory mice exhibited a 
random distribution of apoptotic osteocytes in cortical bone (Aguirre, Plotkin et al. 2006).  In 
rabbit tibial midshaft, Hedgecock demonstrated the first quantitative evidence of a regional and 
linear correlation between osteocyte apoptosis and intracortical remodeling in animals that 
normally remodel their bone (Hedgecock, Hadi et al. 2007).    
Osteocyte ablated mice were resistant to unloading induced bone loss and osteoclastic 
resorption.  Instead they displayed characteristics of fragile bone indicating that osteocytes play 
a crucial role in the sensing of mechanical changes caused by unloading (Tatsumi, Ishii et al. 
2007).   Osteocytes may serve as beacons for osteoclast recruitment and the targeted initiation 
of bone remodeling (Manolagas 2000). 
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Detection of Apoptosis 
Terminal deoxynucleotidyl transferase nick end labeling (TUNEL) is a method used to 
detect apoptotic cell death by end labeling fragmented DNA.  Morphologically, DNA 
degradation of apoptotic cells generates DNA fragments within the nucleus through 
endonucleases (Wyllie, Kerr et al. 1980).  Using Terminal Deoxynucleotidyl Transferase, 
Recombinant (rTdT) enzyme, the assay incorporates biotinylated nucleotide at the 3’-OH DNA 
ends.  Horseradish peroxidase-labeled streptavidin binds to the biotinylated nucleotides.  A DAB 
solution composed of peroxidase substrate, hydrogen peroxide, and diaminobenzidine detects 
the biotinylated nucleotides causing the apoptotic nuclei to stain dark brown. 
A methyl green counterstain is used to detect all viable osteocytes.  Viable nuclei are 
stained blue-green, clearly distinguishing them from the dark brown TUNEL stained nuclei. 
Other signaling mechanisms (BMPs) 
Although there is much evidence suggesting osteocytes as the mechanosensors 
responsible for initiating bone remodeling, another theory suggests variations in bone 
morphogenetic proteins (BMPs) could play a role in initiating bone remodeling.  BMPs are local 
regulators of osteoblast differentiation from mesenchymal cells that promote osteoblastic 
maturation and function.  BMP’s can be regulated by extracellular antagonists produced by 
osteocytes, which bind to BMPs, preventing signaling and thereby affecting osteoblast and 
BMU activity.  Examples include noggin, gremlin, follistatin, and sclerostin.  Osteocyte apoptosis 
may affect levels of BMP antagonists, thereby providing a possible signaling pathway in bone 
remodeling. 
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1.5 Study Goals 
 
The objective of this study is to calculate the density of apoptotic and viable osteoctyes 
by region and quadrant in unloaded murine cortical bone and attempt to correlate their 
regional variability with possible factors that signal bone remodeling.  A previous study has 
quantified and correlated the regional variability of osteocyte apoptosis and bone remodeling 
in rabbit tibial midshafts (Hedgecock, Hadi et al. 2007).  This study will focus on the right hind 
tibia of murine specimens.  Densities of osteocytes will be compared between four anatomic 
quadrants (cranial, caudal, lateral, and medial) and three regions (proximal, midshaft, and 
distal) of the limb.  A spatial correlation between the distribution of apoptotic osteocytes and 
levels of chemoattractants measured in a previous study will be examined.  If a correlation 
exists, we can hypothesize that osteocytes undergoing apoptosis regulate the signal that directs 
bone remodeling.  To further pursue this hypothesis, a future study will investigate the regional 
variability of apoptotic osteocytes in loaded murine cortical bone.  The subjects in the current 
study will be used as control animals.   
As the search for a better understanding of bone remodeling continues, more attention 
is being directed towards osteocyte viability and its role in guiding bone turnover.  Bone 
diseases such as osteoporosis are commonly characterized by an imbalance during this process 
in which the rate of osteoclasts resorbing bone differs from the rate of osteoblasts forming 
bone.  This results in an overall loss in bone mass and strength.  Apoptotic osteocytes disrupt 
the osteocyte network responsible for maintenance of the skeleton making them a therapeutic 
target in the treatment of bone disorders and prevention of bone loss.  
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II. MATERIALS AND METHODS 
Four C57 Black 6 Taconic mice (C57Bl/6) were procured at 7 to 9 weeks of age (Taconic, 
Oxnard, CA), housed in microisolation chambers at the University’s vivarium, and sacrificed at 8 
to 12 weeks of age.  A previous study on male and female C57Bl/6 measured the changes in 
cortical bone and length of tibiae, bone weight, and composition to determine skeletal maturity 
which occurred between 3 and 6 months(Somerville, Aspden et al. 2004).  Since the mice used 
in this study were sacrificed at around 3 months, they appear to have reached young adulthood 
and possibly full skeletal maturity.  
2.1 Sacrifice 
 
Perfusion fixation was performed on each animal by being anesthetized with 25% 
Avertin (0.15ml/10g) through an intraperitoneal injection and placed on a heating pad.  Shaved 
limbs were taped to the heating pad and the skin was separated from the muscle between the 
abdomen and thoracic cavity.  A thoracotomy was performed and a small incision was made in 
the left ventricular apex to inject a heparinized vasodilator cocktail followed by a perfusion of 
Histochoice (Amresco) to fix the animal.  A small incision was made in the hindlimb to observe 
clearance of blood. Once fixed, limbs were dissected and placed in microcentrifuge tubes with 
Histochoice to post fix at 4 degrees Celsius.  
Hindlimb samples were transferred into a decalcification solution to soften the bone 
prior to embedding for 3 to 4 days. The decalcification solution was composed of 150 grams 
disodium EDTA dehydrate and 15 grams NaOH.  Water was added until the pH of the solution 
reached 7.4 (between 700-800ml), yielding an approximate 15% EDTA solution.  
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2.2 Specimen Preparation and Processing  
 
Following sacrifice, tissue fixation, and decalcification, processing followed.  Once the 
bones were softened and decalcification was completed, the limbs were placed in a tissue 
processor.  After dehydration, tissue samples were embedded in paraffin using the Shandon 
Excelsior ES system (Thermo Fisher Scientific, Waltham, MA).  Sections 7 µm thick were cut 
from each block using the Leica RM2255 rotary microtome (Leica Microsystems, Bannockburn, 
IL).  Sections were floated on a warm distilled water bath (Boekel Scientific, Feasterville, PA) 
and adhered to the slides (Thermo Fisher Scientific).  Two wrinkle free sections were placed on 
each slide and allowed to air dry for 24 hours.  To prepare for staining, slides were incubated in 
a 40˚C oven for twenty minutes or until the paraffin lost its opacity.  Sections were stained 
using the DeadEnd Colorimetric TUNEL (Terminal deoxynucleotidyl transferase (TdT)-mediated 
deoxyuridine triphosphate nick-end labeling) System (Promega Corp., Madison, WI) to identify 
cellular DNA fragmentation characteristic of apoptosis. 
2.3 TUNEL staining and Osteocyte Apoptosis 
 
Sections were deparaffinized in xylene for 5 minutes, rehydrated by a graded alcohol 
series (8 minutes in 100%, 3 minutes in 95%, 3 minutes in 85%, 3 minutes in 70%, and 3 minutes 
in 50%), and then set out to air dry for 20 minutes.   After a 5 minute phosphate buffered saline 
(PBS) rinse, sections were refixed in Histochoice for 15 minutes.  A 20µg/mL proteinase K 
solution was used to digest the sections for 10 minutes at room temperature.  After PBS rinses 
and another refixing in Histochoice, equilibration buffer was placed on the slides for 10 
minutes.  After equilibration, 100 µL of the TUNEL reaction mixture (1 part biotinylated 
nucleotides, 1 part rTdT enzyme, and 98 parts buffer) was added to each section and then 
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covered with plastic coverslips to evenly distribute the reagent.  Sections were allowed to 
incubate (1 hour in a humidifying chamber at 37˚C) which allowed the nick end-labeling 
reaction to occur.  Sections were placed in a sodium-chloride sodium-citrate (SSC) wash to 
terminate the reaction, followed by PBS rinses to remove unincorporated biotinylated 
nucleotides.  Then they were treated with 0.3% H2O2 for 5 minutes to block endogenous 
peroxidases, rinsed in PBS, and treated with streptavidin horseradish peroxidase for 30 
minutes.  After PBS rinses, slides were developed for approximately 10 minutes with 
diaminobenzidine (DAB) substrate for visualization of the peroxidase.  Slides were rinsed briefly 
in distilled water and then mounted with Permount (Thermo Fischer Scientific) and 
coverslipped.  Slides that served as positive controls were treated with DNase I (Promega Corp., 
Madison, WI) to artificially create DNA fragmentation while slides with no rTdT enzyme in the 
reaction mixture served as the negative control.  Positive and negative controls were stained 
separately to prevent contamination. 
To reveal non apoptotic nuclei separate sections were deparaffinized in xylene for 5 
minutes, rehydrated by a graded alcohol series (8 minutes in 100%, 3 minutes in 95%, 3 
minutes in 85%, 3 minutes in 70%, and 3 minutes in 50%), and then set out to air dry for 20 
minutes.  Sections were then rinsed briefly in deionized water for 5 minutes, stained with 2% 
methyl green (Aldrich Chemical Co., St. Louis, MO) for 30 seconds, and then rinsed briefly in 
distilled water (until clear).  All slides were mounted with Permount (Thermo Fischer Scientific) 
and coverslipped.   
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2.4 Image Capture, Processing, and Analysis 
 
To quantify osteocyte apoptosis, slides were observed under full-spectrum white light 
using a BX41 polarizing light microscope (Olympus Optical Co., Ltd., Center Valley, PA) at 40x 
magnification.  Images were captured using a Retiga EXi color camera (QImaging, Surrey, BC, 
Canada) and the Q Capture Pro imaging program (QImaging).   Using Adobe Photoshop, 
individual images were combined to create a single image of the entire cross section.  A Ronchi 
ruler with known lines at a size of 150 lines per mm was used to calibrate the images at 40x 
magnification.  Image analysis was performed using Image J (Wayne Rashband(NIH)) where 
images were calibrated with the Ronchi ruler, yielding total field dimensions of 0.23 mm by 0.17 
mm.   Bone area was measured in square millimeters using the freehand selection tool. 
                                  
Figure 7.  Cross sectional views of murine right tibia (A) TUNEL stained sections. (B) Methyl 
green stained sections.  Cr=cranial, Ca=caudal, M=medial, L=lateral.  To the right is an image 
of a right tibia and fibula divided regionally.   
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For analysis, each cross section of bone was divided into four anatomic quadrants 
(cranial, lateral, caudal, and medial) and three regions (proximal, medial, and distal) along the 
entire bone (Figure 7).  Osteocyte lacunae were divided into three categories based on the 
staining of their nucleus: brown (Br), blue (Bl), and empty.  Lacunae with brown nuclei 
represented TUNEL- positive cells, apoptotic osteocytes (Figure 8), while lacunae with blue 
nuclei represented TUNEL-negative cells, viable osteocytes (Figure 9).   Empty lacunae were 
characterized by a distinct lacunar wall (Figure 8).  Similarly, stained cells were only counted 
that resided within lacunae, eliminating cells residing in Haversian spaces, cells that accidentally 
migrated over bone tissue during the staining procedure, or cells located in a different plane.   
The frequency of osteocyte apoptosis and viable osteocytes were expressed as a percentage of 
total cells and a density (number per unit tissue area).  Total lacunar density was found as well.  
Osteocyte percentage and density were measured within each of the four quadrants and across 
the three regions as well as total osteocyte density per subject. 
 
Figure 8.  TUNEL stained image. 
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Figure 9. Methyl green stained image. 
2.5 Statistical Analysis 
 
Data was tested using general linear models (GLM, ANOVA) in Minitab 16 (Minitab) to 
measure the differences in apoptotic osteocyte density, viable osteocyte density, total lacunar 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes.  General 
linear models were performed to test the differences of the interaction using factors of 
quadrant and region across all subjects along with Tukey’s comparison.  P values less than 0.05 
were considered significant. 
Regression analyses were performed using BMP antagonist expression levels found in a 
previous study.   BMP expression level was compared to apoptotic osteocyte density, viable 
osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and percentage of 
viable osteocytes at each of the twelve region/quadrant combinations.  A regression test on 
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slope determined whether there was a significant relation or not.  If the slope equaled zero, no 
relation could be determined. 
2.6 BMU Identification 
 
 BMU’s are three dimensional units used to quantify bone remodeling that typically 
travel through cortical bone in a longitudinal direction.  When examining cross sectional views 
of bone, BMU’s can be identified two dimensionally by their unique morphological features.  
The most distinct is the cement line that defines the boundary of the secondary osteon.  Within 
the cement wall lies a space for the Haversian canal surrounded by concentric lamellae.  The 
radius of the lamellae depends on the remodeling stage of the osteon.  An example of a BMU 
can be seen in Figure 10.  For analysis, BMUs were identified across all subjects by region and 
quadrant. 
 
 
Figure 10.  BMU within murine cortical bone.  The arrow marks the outline of cement wall. 
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III. RESULTS 
3.1 Osteocyte Densities 
  
A summary of apoptotic osteocyte density, viable osteocyte density, total lacunar 
density, percentage of apoptotic osteocytes, and percentage of viable osteocytes from all 
individual subjects are listed in Table 1.  The total lacunar density was compared to previous 
studies measuring osteocyte densities in mice to validate this study.  A similar study looking at 
BMP antagonist expression levels and using some of the same mice as the current study 
produced an overall osteocyte density of 676 per mm
2
 in mice hindlimbs (Mosher 2010).  When 
the effect of osteoprotegerin, a protein affecting the formation of osteoclasts was studied, 
densities of 750-800 per mm
2
 were reported in mice tibial diaphysis using H and E staining 
(Bucay, Sarosi et al. 1998).  Our measurements yielded a total lacunar density of 599 per mm
2
 
with a standard deviation of 121 per mm
2
.  While this number was slightly lower than the 
densities found in the Bucay study, it was similar to the density calculated by Mosher. 
Table11.  Apoptotic osteocyte density, viable osteocyte density, total lacunar density, 
percentage of apoptotic osteocytes, and percentage of viable osteocytes by individual 
subjects.  Standard deviations in parentheses. 
 
SUBJECT APOPTOTIC 
OSTEOCYTE 
DENSITY(#/mm
2
) 
PERCENTAGE 
APOPTOTIC 
OSTEOCYTES(%) 
TOTAL LACUNAR 
DENSITY(#/mm
2
) 
VIABLE 
OSTEOCYTE 
DENSITY(#/mm
2
) 
PERCENTAGE 
VIABLE 
OSTEOCYTES(%) 
45 217.91 41.53 556.33 396.33 67.36 
90 248.58 37.96 738.62 697.07 75.67 
93  210.30 33.38 645.56 476.71 71.69 
94 72.14 17.48 455.70 353.61 70.88 
Overall 187.2(78.5) 32.59(10.61) 599.1(121.1) 480.9(152.9) 71.40(3.41) 
 
 Mean values and standard deviations of apoptotic osteocyte density, viable osteocyte 
density, total lacunar density, percentage of apoptotic osteocytes, and percentage of viable 
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osteocytes across all subjects by quadrant are summarized in Table 2.  Results from the general 
linear models are shown in appendix A.  Quadrantal mean values and standard deviations 
across all subjects from individual regions were calculated in Tables 2a-2c. P-values comparing 
the differences between each quadrant are also listed.   
As displayed in Table 2, no significant differences appear in apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, or 
percentage of viable osteocytes between quadrant comparisons.  Similarly, no differences 
appeared when all subjects were analyzed by region (Table 2a-2c). 
 
Table22.  Quadrantal differences of apoptotic osteocyte density, viable osteocyte density, 
total lacunar density, percentage of apoptotic osteocytes, and percentage of viable 
osteocytes across all subjects.  Standard deviations in parentheses. 
 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 205.1(83.2) 33.99(11.20) 641.9(131.0) 518.8(161.7) 71.43(3.21) 
Caudal(Cd) 159.8(67.2) 30.06(10.36) 554.5(105.4) 445.5(158.4) 70.56(4.70) 
Medial(M) 200.3(93.5) 30.96(11.00) 668.1(144.7) 510.3(121.1) 70.84(1.75) 
Lateral(L) 189.8(85.5) 35.02(10.84) 544.8(127.2) 440.1(144.4) 73.00(4.25) 
Cr-Cd .7035 .8543 .5681 .6586 .9833 
Cr-M .9688 .7968 .9921 .8579 .9993 
Cr-L .9937 .9935 .9200 .8579 .9983 
Cd-M .9210 .9994 .4045 .7108 .9952 
Cd-L .8434 .9493 .9066 .9828 .9972 
M-L .9975 .9135 .7971 .9998 1.000 
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Table32a.  Mean quadrantal data gathered from the proximal region for apoptotic osteocyte 
density, viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, 
and percentage of viable osteocytes across all subjects.  Standard deviations in parentheses. 
 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Total Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 168.1(69.7) 29.67(9.60) 592.7(111.6) 437.8(93.5) 68.96(4.38) 
Caudal(Cd) 157.7(86.4) 29.59(12.92) 519.6(83.9) 368.0(44.6) 69.15(3.15) 
Medial(M) 164.2(93.6) 28.86(12.28) 600.4(112.4) 453.6(64.4) 68.99(1.32) 
Lateral(L) 156.5(86.0) 32.07(11.85) 478.2(96.8) 357.5(57.6) 72.08(5.49) 
Cr-Cd .9987 1.000 .8153 .6065 .9999 
Cr-M .9999 .9998 .9997 .9912 .9878 
Cr-L .9981 .9940 .5452 .5016 .7658 
Cd-M .9997 .9998 .7683 .4531 .9932 
Cd-L 1.000 .9934 .9574 .9973 .7959 
M-L .9994 .9861 .4957 .3630 .9102 
 
Table42b.    Mean quadrantal data gathered from the midshaft region for apoptotic osteocyte 
density, viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, 
and percentage of viable osteocytes across all subjects.  Standard deviations in parentheses.  
 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 290.67(11.74) 46.16(7.76) 710.6(106.6) 613(176) 73.24(3.42) 
Caudal(Cd) 220.1(41.7) 38.53(8.37) 628.2(69.5) 535(200) 71.04(7.45) 
Medial(M) 294.40(.402) 38.44(3.15) 791.8(78.5) 602.3(105.1) 72.00(1.95) 
Lateral(L) 279.2(50.8) 44.67(4.92) 688.9(34.7) 591.8(68.2) 73.31(4.07) 
Cr-Cd .2889 .6626 .7214 .9486 .9620 
Cr-M .9994 .6555 .7297 .9999 .9926 
Cr-L .9842 .9949 .9908 .9988 1.000 
Cd-M .2593 1.000 .2833 .9651 .9964 
Cd-L .4011 .7790 .8557 .9784 .9585 
M-L .9652 .7722 .5877 .9998 .9912 
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Table52c. Mean quadrantal data gathered from the distal region for apoptotic osteocyte 
density, viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, 
and percentage of viable osteocytes across all subjects.  Standard deviations in parentheses.  
 
Quadrant Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteoctyes 
Total Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Cranial(Cr) 214.7(23.0) 39.44(9.82) 602.2(93.6) 436.0(40.4) 65.00(8.48) 
Caudal(Cd) 148.59(5.18) 31.91(3.36) 511.4(74.9) 360.4(64.3) 62.21(1.89) 
Medial(M) 153.4(42.8) 30.9(15.4) 570(183) 403.1(108.7) 63.10(15.4) 
Lateral(L) 207.1(58.9) 32.31(11.12) 658.4(63.8) 401.33(12.62) 58.10(9.17) 
Cr-Cd .4169 .8934 .8537 .6904 .9912 
Cr-M .4679 .8544 .9913 .9564 .9970 
Cr-L .9967 .9069 .9567 .9497 .8951 
Cd-M .9992 .9996 .9509 .9130 .9997 
Cd-L .5007 1.000 .6140 .9221 .9735 
M-L .5584 .9990 .8637 1.000 .9551 
 
Mean values and standard deviations of apoptotic osteocyte density, viable osteocyte 
density, total lacunar density, percentage of apoptotic osteocytes, and percentage of viable 
osteocytes across all subjects by region are summarized in Table 3.  Results from the general 
linear models are listed in appendix A.   Table 3 demonstrates significant differences between 
the proximal and midshaft regions in the apoptotic osteocyte density, percentage of apoptotic 
osteocytes, total lacunar density, and viable osteocyte density.  The percentage of viable 
osteocytes showed a significant difference between the proximal and distal regions, while the 
apoptotic osteocyte density, viable osteocyte density, and percentage of viable osteocytes 
showed a significant difference between the midshaft and distal regions.  Regional mean values 
and standard deviations across all subjects from individual quadrants were listed in Table 3a-3d.  
A significant difference was only seen in the viable osteocyte density of the lateral quadrant 
between the proximal and midshaft regions.  Furthermore, the viable osteocyte density in the 
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lateral quadrant showed a marginally significant difference between the midshaft and distal 
regions. 
 
Table63. Regional differences of apoptotic osteocyte density, viable osteocyte density, total 
lacunar density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
across all subjects.  Standard deviations in parentheses. 
 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Proximal(P)  160.5(77.4) 29.84(10.90) 547.4(95.4) 403.1(66.9) 69.79(3.64) 
Midshaft(MS) 266.0(24.7) 42.54(6.48) 689.7(69.2) 584(160) 72.46(4.54) 
Distal(D) 180.3(22.22) 34.29(8.94) 574.0(93.9) 399.2(54.6) 62.64(7.10) 
P-MS .0009 .0176 .0047 .0002 .5930 
P-D .7431 .6510 .6783 .9940 .0073 
MS-D .0113 .1627 .0563 .0005 .0016 
 
 
 
 
Table73a. Mean regional data gathered from the cranial quadrant for apoptotic osteocyte 
density, viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, 
and percentage of viable osteocytes across all subjects.  Standard deviations in parentheses. 
 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Proximal(P)  168.1(69.7) 29.67(9.60) 592.7(111.6) 437.8(93.5) 68.96(4.38) 
Midshaft(MS) 290.67(11.74) 46.16(7.76) 710.6(106.6) 613(176) 73.24(3.42) 
Distal(D) 214.7(23.0) 39.44(9.82) 602.2(93.6) 436.0(40.4) 65.00(8.48) 
P-MS .1187 .2378 .5051 .3078 .6976 
P-D .6136 .5329 .9948 .9998 .7304 
MS-D .3855 .7613 .6035 .3532 .3858 
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Table83b. Mean regional data gathered from the caudal quadrant for apoptotic osteocyte 
density, viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, 
and percentage of viable osteocytes across all subjects.  Standard deviations in parentheses. 
 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total 
Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Proximal(P)  157.7(86.4) 29.59(12.92) 519.6(83.9) 368.0(44.6) 69.15(3.15) 
Midshaft(MS) 220.1(41.7) 38.53(8.37) 628.2(69.5) 535(200) 71.04(7.45) 
Distal(D) 148.59(5.18) 31.91(3.36) 511.4(74.9) 360.4(64.3) 62.21(1.89) 
P-MS .5847 .6363 .3745 .3219 .8905 
P-D .9869 .9667 .9929 .9968 .3073 
MS-D .5594 .8027 .3855 .3479 .2305 
 
 
 
 
 
Table93c. Mean regional data gathered from the medial quadrant for apoptotic osteocyte 
density, viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, 
and percentage of viable osteocytes across all subjects.  Standard deviations in parentheses. 
 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total 
Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Proximal(P)  164.2(93.6) 28.86(12.28) 600.4(112.4) 453.6(64.4) 69.99(1.32) 
Midshaft(MS) 294.40(40.2) 38.44(3.15) 791.8(78.5) 602.3(105.1) 72.00(1.95) 
Distal(D) 153.4(42.8) 30.90(15.4) 570(183) 403.1(108.7) 63.1(15.4) 
P-MS .2160 .6705 .3298 .2672 .9576 
P-D .9842 .9809 .9641 .8147 .6322 
MS-D .2212 .8037 .2995 .1743 .5424 
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Table103d. Mean regional data gathered from the lateral quadrant for apoptotic osteocyte 
density, viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, 
and percentage of viable osteocytes across all subjects.  Standard deviations in parentheses. 
 
Region Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total 
Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Proximal(P)  156.5(86.0) 32.07(11.85) 478.2(96.8) 357.5(57.6) 72.08(5.49) 
Midshaft(MS) 279.2(50.8) 44.67(4.92) 688.9(34.7) 591.8(68.2) 73.31(4.07) 
Distal(D) 207.1(58.9) 32.31(11.12) 658.4(63.8) 401.33(12.62) 58.10(9.17) 
P-MS .2628 .4513 .0852 .0188 .9757 
P-D .7405 .9997 .1297 .6695 .1485 
MS-D .6155 .5159 .9200 .0502 .1510 
 
3.2 Regression Analysis 
 
Linear regression analysis of BMP antagonist levels versus apoptotic osteocyte density, 
viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, and 
percentage of viable osteocytes was performed (Figures 11-15).  Levels of BMP antagonists, 
noggin and gremlin, were used from a previous study (Mosher 2010) and shown in Table 4.  
Noggin expression displayed an overall negative correlation except in the percentage of viable 
osteocytes but showed a significant relationship in the percentage of apoptotic osteocytes and 
marginally significant relationships with viable osteocyte density and percentage of viable 
osteocyte  Conversely, gremlin expression demonstrated all positive correlations and significant 
relationships between expression and apoptotic osteocyte density, viable osteocyte density, 
total lacunar density, percentage of apoptotic osteocytes, and percentage of viable osteocytes 
(Table 5).  
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Table114. BMP antagonist levels (Mosher 2010). 
Region Quadrant Noggin Gremlin 
Proximal Cranial 2.33 1.59 
Midshaft Cranial 1.75 2.02 
Distal Cranial 2.35 1 
Proximal Caudal 2.63 1.47 
Midshaft Caudal 2 1.98 
Distal Caudal 1.96 1 
Proximal Medial 2.49 1.47 
Midshaft Medial 2.06 1.87 
Distal Medial 1.76 1 
Proximal Lateral 2.55 1.38 
Midshaft Lateral 1.8 1.97 
Distal Lateral 2.14 1.5 
 
 
 
Table125. Linear relationships between BMP antagonist expression and apoptotic osteocyte 
density, viable osteocyte density, total lacunar density, percentage of apoptotic osteocytes, 
and percentage of viable osteocytes. 
 
Noggin  Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Slope -0.0029 -0.0311 -0.0018 -0.0018 0.0029 
R
2
 0.2696 0.3572 0.2563 0.3101 0.0020 
P-value 0.0836 0.0401 0.0931 0.0600 0.8890 
 
Gremlin  Apoptotic 
Osteocyte 
Density 
%Apoptotic 
Osteocytes 
Total Lacunar 
Density 
Viable 
Osteocyte 
Density 
%Viable 
Osteocytes 
Slope 0.005 0.0372 0.0029 0.0032 0.054 
R
2
 0.5382 0.3397 0.4480 0.6595 0.4796 
P-value 0.0066 0.0467 0.0173 0.0013 0.0125 
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Figure 11. Regression analysis of BMP expression versus apoptotic osteocyte density.  Data 
from proximal region is represented with the diamond (♦) symbol, midshaft region is 
represented with the circle (●) symbol, and distal region is represented with the triangle (▲) 
symbol.  Cranial, caudal, medial, and lateral points are colored blue, red, green, and yellow 
respectively.  All points indicating noggin levels are solid shapes, while all points indicating 
gremlin levels are shape outlines. 
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Figure 12. Regression analysis of BMP expression versus percentage of apoptotic osteocytes. 
Data from proximal region is represented with the diamond (♦) symbol, midshaft region is 
represented with the circle (●) symbol, and distal region is represented with the triangle (▲) 
symbol.  Cranial, caudal, medial, and lateral points are colored blue, red, green, and yellow 
respectively.  All points indicating noggin levels are solid shapes, while all points indicating 
gremlin levels are shape outlines. 
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Figure 13.  Regression analysis of BMP expression versus total lacunar density. Data from 
proximal region is represented with the diamond (♦) symbol, midshaft region is represented 
with the circle (●) symbol, and distal region is represented with the triangle (▲) symbol.  
Cranial, caudal, medial, and lateral points are colored blue, red, green, and yellow 
respectively.  All points indicating noggin levels are solid shapes, while all points indicating 
gremlin levels are shape outlines. 
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Figure 14.  Regression analysis of BMP expression versus viable osteocyte density. Data from 
proximal region is represented with the diamond (♦) symbol, midshaft region is represented 
with the circle (●) symbol, and distal region is represented with the triangle (▲) symbol.  
Cranial, caudal, medial, and lateral points are colored blue, red, green, and yellow 
respectively.  All points indicating noggin levels are solid shapes, while all points indicating 
gremlin levels are shape outlines. 
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Figure 15. Regression analysis of BMP expression versus percentage of viable osteocytes. 
Data from proximal region is represented with the diamond (♦) symbol, midshaft region is 
represented with the circle (●) symbol, and distal region is represented with the triangle (▲) 
symbol.  Cranial, caudal, medial, and lateral points are colored blue, red, green, and yellow 
respectively.  All points indicating noggin levels are solid shapes, while all points indicating 
gremlin levels are shape outlines. 
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3.3 BMU Analysis 
 Our samples showed low levels of BMU activity which was to be expected due to their 
unloaded condition.  The summary of the number of BMUs positively identified by quadrant 
and region is shown in Table 6. 
 
Table136.  Number of BMUs identified across all subjects  
Region Quadrant BMUs 
Proximal Cranial 3 
Proximal Caudal 2 
Proximal Medial 0 
Proximal Lateral 1 
Midshaft Cranial 2 
Midshaft Caudal 1 
Midshaft Medial 0 
Midshaft Lateral 0 
Distal Cranial 0 
Distal Caudal 0 
Distal Medial 0 
Distal Lateral 0 
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IV. DISCUSSION 
 
The objective of this study was to investigate apoptotic osteocytes as a possible 
regulator of signaling factors in the bone remodeling process.  The frequency of osteocyte 
apoptosis was measured by region (proximal, midshaft, and distal) and quadrant (cranial, 
caudal, lateral, and medial) in unloaded murine cortical bone.  To determine variability, their 
spatial distribution was correlated with the location of levels of the BMP antagonists, noggin 
and gremlin, that were measured in a previous study.  The distribution of total lacunar density 
and viable osteocyte frequencies were quantified as well and correlated with the same BMP 
antagonist levels.  We hypothesized that a variation in the location of apoptotic osteocytes 
would coincide with varying levels of either one or both of the BMP antagonists.  BMP 
antagonist expression is thought to play a role in the initiation of bone remodeling.  If a 
correlation does exist, we believe that osteocytes undergoing apoptosis are part of the 
regulatory mechanism that stimulates and directs bone remodeling in a spatial and temporal 
manner.  If no correlation can be made, then apoptotic osteocytes may not affect the signaling 
pathway responsible for bone remodeling.  Using mice as models were advantageous because 
they are small, affordable, easily obtained, and may be used for gene expression studies in the 
future.  Analysis was performed on the tibial hindlimbs as opposed to forelimbs because of 
their larger cross sectional area and easy subjection to mechanical loading that will be 
performed in future studies. 
Previous correlations of apoptotic osteocytes with high rates of bone turnover sparked 
the possibility of a tight spatial and temporal link between dying osteocytes and fatigue induced 
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microdamage followed by subsequent remodeling.  After it was confirmed apoptosis was not a 
result of remodeling but rather a part of the pathway leading to it, a causal pathway linking 
apoptotic osteocytes and the regulation of bone remodeling was established.  Rat bones 
subjected to hyperphysiological strains produced apoptotic osteocytes in areas surrounding 
microdamage that were preceded by the tunneling of osteoclasts, a marker of the beginning of 
bone resorption (Noble, Peet et al. 2003).  As the mechanosensors within bone, osteocytes and 
their viability greatly influence bone remodeling.   Osteocyte ablated mice showed altered 
activities of osteoclasts and osteoblasts during unloading induced bone loss (Tatsumi, Ishii et al. 
2007).  Similarly, without the apoptosis of osteocytes, remodeling cannot occur.  An in vivo rat 
ulnar model used a pan caspace inhibitor to suppress osteocyte apoptosis that normally 
resulted from fatigue induced microdamage.  As a result, the activation of osteoclastic 
resorption within the cortex was completely prevented.  This proved that not only was 
apoptosis necessary to stimulate activation of intracortical remodeling but also that osteoclastic 
resorption was directly related to the amount of apoptosis.  A possible dose-response 
relationship may exist further emphasizing the role apoptotic events play in determining the 
course of remodeling (Cardoso, Herman et al. 2009).  In addition to a temporal relationship, a 
spatial relationship between apoptotic osteocytes and bone remodeling exists.  The location of 
apoptotic osteocytes within bone may guide osteoclasts to a targeted location for bone 
resorption to begin.   A study on mice performed ovariectomies to induce bone loss by creating 
an estrogen deficiency.  Osteocyte apoptosis occurred in the femoral cortical bone in a certain 
area of the cortex that coincided with the region of subsequent bone resorption (Emerton, Hu 
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et al. 2009).   It is clear that the death of osteocytes, not other bone cell types, triggers the 
activation of localized remodeling of bone. 
Since the crucial role of apoptosis has become apparent, current studies have focused 
on looking at its triggers in an attempt to gain a more complete understanding of the how it 
affects bone turnover.  The trigger for apoptosis could come from a variety of sources including 
molecular mechanisms, chemoattractants, or a cellular source of signals.  Apoptotic osteocytes 
themselves may release a signal that initiates a bone remodeling response.  An in vivo study 
showed that osteocyte apoptotic bodies are capable of initiating osteoclastic bone resorption 
without the addition of pro osteoclastogenic factors.  Osteocyte apoptotic debris was shown to 
stimulate osteoclasts (Kogianni, Mann et al. 2008).   Alternatively, apoptosis may be controlled 
by various gene products.   Finding its exact selective mechanism remains difficult because it is 
regulated by the interaction of many molecules through several different pathways.  Bax and 
Bcl-2 are two gene products that control apoptosis in a complimentary pathway.  Surrounding 
areas of microcracks in fatigue loaded rats, Bax expression promoted osteoctye apoptosis while 
Bcl-2 expression seen at a distance from microdamage protected cells from undergoing 
apoptosis.  Surviving cells could be a signal source or promote an osteoclast response by 
releasing an anti apoptotic response in areas surrounding apoptotic osteocytes (Verborgt, 
Tatton et al. 2002).  In addition, sclerostin, a protein product of the SOST gene, has been shown 
to initiate apoptosis through the activation of caspace 3.  Sclerostin is a negative regulator of 
bone formation through the modulation of osteoblast function and survival (Sutherland, 
Geoghegan et al. 2004).  Expression of this gene was detected strongly in osteocytes suggesting 
its role in bone homeostasis (Winkler, Sutherland et al. 2003).  Apoptosis is regulated by the 
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interaction of many molecules through different pathways.  While its selective mechanism 
remains a mystery, its importance in the skeletal development and regulation of bone 
regeneration makes it a key topic for current research. 
Quantifying the number and location of apoptotic osteocytes within bone is helpful in 
determining where and how bone remodeling is targeted.  In a previous study, Hedgecock 
measured the regional variability in bone turnover parameters, osteocyte apoptosis, and 
osteocyte density in rabbit tibial midshafts.  Cross sectional areas of bone were divided into 
cranial, caudal, lateral, and medial quadrants.  A significant correlation was found in areas 
between bone remodeling parameters and osteocyte apoptosis suggesting they release a signal 
that attracts or directs bone remodeling (Hedgecock, Hadi et al. 2007).   Further investigation 
into the precise location of apoptotic osteocytes within bone and their relation to other 
possible bone remodeling stimuli will offer important information.  Taking a look at regional 
factors associated with bone remodeling, Mosher quantified regional and quadrantal 
differences of BMP antagonist levels and osteocyte densities in unloaded murine cortical bone.  
He compared BMP antagonist expression levels with varying osteocyte densities.  While no 
significant differences were shown between quadrants, significant regional differences were 
found between the BMP antagonist levels of gremlin and osteocyte densities indicating some 
sort of relationship and influence on bone remodeling (Mosher 2010).   
The results of this study focused on quantifying the variation of apoptotic osteocytes in 
the cross sectional area of unloaded mice hindlimbs in an attempt to provide more insight into 
possible factors of initiation for bone remodeling.  By comparing the results to Mosher’s 
previous study measuring BMP antagonist levels, we were able to provide interesting results 
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and affirmation of our initial hypothesis.   Similar regions and quadrants were analyzed in both 
studies to make drawing correlations and comparisons easier. 
Quadrantal Analysis 
 
While the cranial region had the highest density of apoptotic osteocytes and the lateral 
region had the highest percentage of apoptotic osteocytes, no statistical difference was found 
in the distribution of osteocytes within quadrants.  No quadrantal differences were seen in the 
percentage of apoptotic osteoctyes, total lacunar density, viable osteocyte density, and 
percentage of viable osteocytes as well.  Mosher’s study showed similar results with no 
differences between quadrants with respect to viable osteocyte density, total lacunar density, 
percentage of viable osteocyte, and gremlin expression (Mosher 2010).  This overall lack of 
variation among quadrants is not uncharacteristic of unloaded bone conditions. 
Regional Analysis 
 
While there was a lack of quadrantal differences, regional variations were found 
between subjects supporting our hypothesis of regional variation in osteocyte apoptosis.  A 
significantly higher density of apoptotic osteocytes in the midshaft region was seen in 
comparison to both proximal and distal regions.  Also, a greater percentage of apoptotic 
osteocytes were observed in the midshaft region compared to the proximal region.  
Coincidentally, in Mosher’s previous study, the midshaft region demonstrated higher gremlin 
expression than both the proximal and distal regions as well (Mosher 2010).  This indicates 
some relationship between BMP antagonists and apoptotic osteocytes that is confirmed by the 
regression analysis.  Regression analysis of gremlin showed significant moderate positive linear 
correlations between gremlin expression and apoptotic osteocyte density (R
2
=.54, p-value=.01) 
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and the percentage of apoptotic osteocytes (R
2
=.34, p-value=.05).  While regression analysis for 
noggin showed a negative linear correlation for the percentage of apoptotic osteocytes (R
2
=.36, 
p-value=.04), no other significant correlations were established.   
Regional differences were also noted in the total lacunar density, where midshaft 
densities were significantly higher than the proximal densities.  Regression analysis of gremlin 
showed a significant positive linear correlation between its expression and total lacunar density 
(R
2
=.45, p-value=.02) while no correlation was seen in noggin expression. 
Viable osteocyte densities in the midshaft were higher than in the proximal and distal 
regions while the percentage of viable osteocytes was higher in the proximal and midshaft 
when compared to the distal region.  This is comparable to Mosher’s regional analysis in which 
the midshaft had greater viable osteocyte densities than the proximal and distal region.  A 
significant positive correlation between gremlin expression and viable osteocyte density 
(R
2
=.66, p-value=.00) and the percentage of viable osteocytes (R
2
=.48, p-value=.01) was 
established through regression analysis. 
Comparing our results to BMP antagonists gives new insight into possible factors 
controlling bone remodeling.  Regional differences found in previous and the current study 
suggest the midshaft as a possible target location for osteoclast recruitment in remodeling  
since an increase in all osteocyte densities occurred in that specific region.  Furthermore a 
positive correlation was made between gremlin and apoptotic osteocytes, viable osteocytes, 
and total osteocytes in both studies suggesting gremlin could be an important part of the 
signaling pathway responsible for bone resorption.  These possibilities are helpful in honing in 
on the exact mechanism responsible for bone remodeling. 
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This study confirmed the hypothesis that a variation in the location of apoptotic 
osteocytes coincided with a variation in the BMP antagonist levels of gremlin within unloaded 
bone.  While a direct link between viable or apoptotic osteocytes and gremlin has not been 
established, the close association between the gene product sclerostin, apoptosis, and bone 
morphagenic protein antagonists suggests the need for a further investigation of these possible 
initiation factors.  Since bone morphagenic proteins are responsible for skeletal homeostasis 
and bone growth, the binding of their antagonists to them prevents them from binding to 
signaling factors, causing BMPs to lose control of bone formation.  The two extracellular 
antagonists, noggin and gremlin, used for comparison in this study, have been previously 
examined separately to explore their individual role in bone formation.  In vivo overexpression 
of these BMP antagonists was conducted in mice using an osteocalcin promoter.  Noggin is 
known to decrease the effects of BMPs on osteoblast function and impair osteoblastgenesis 
and osteoclastgenesis.  Overexpression caused a decrease of trabecular bone volume due to a 
decrease in osteoblastic activity but not osteoblast number (Devlin, Du et al. 2003).  Similarly, 
over expression of gremlin has been shown to lead to bone loss.  Gremlin is expressed in 
osteoblasts and increases after BMP exposure.  It regulates BMP activity by a local feedback 
mechanism.  Skeletal markers showed a decrease in bone mineral density and overall 
weakening of the bone.   The number of osteoclasts and osteoblasts was shown to decrease 
indicating decreased bone remodeling.  Mechanisms of inhibition included a reduction in the 
replication of the osteoblasts or differentiation of mesenchymal stem cells toward mature 
osteoblasts (Gazzerro, Pereira et al. 2005).  Overexpression of both noggin and gremlin in mice 
led to an overall inhibition of bone formation.  Both bind to BMP-2,-4, and -7 which play a key 
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role in the regulation of bone function and fracture repair, but noggin binds with a higher 
affinity than gremlin (Zhao, Harris et al. 2002).  Overall BMP antagonists have been shown to 
play a role in the formation of bone especially in controlling osteoblast function.  However, 
their specific activities in terms of interacting with BMPs, each other, bone remodeling, and 
apoptosis is still under investigation.   
 The exact role of osteocyte death in the signaling of bone remodeling remains unclear.  
Whether apoptotic osteocytes release a stimulatory or inhibitory signal, or are the actual signal 
itself, they somehow activate the initiation of targeted bone remodeling along with other 
various factors in the signaling cascade.  A better understanding of this remains a topic of much 
current research.  
Limitations 
 
Several limitations have been made in the current study.  Subjects were housed in the 
University’s vivarium and looked after by other students.  Since no external loads were applied, 
we assumed each subject had similar daily activity levels as we were unable to monitor them.  
Differences in activity levels could have affected the levels of mechanically induced bone 
remodeling and therefore osteocyte levels.  The mice used in the current study and Mosher’s 
previous study were assumed to experience the same daily activity levels so comparisons could 
be easily made between the two.  
Using histology presented some limitations as well.  The majority of the tissue gathering 
including sample sacrifice, fixation, decalcification, tissue processing, and embedding was 
handled by other lab students using similar samples but performing different studies.  As a 
result, bone samples were processed and sectioned with the surrounding muscle tissue 
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attached.  While the muscle tissue acted as a guide in helping determine the orientation of the 
bone, it was excess that may have contributed to problems arising while sectioning using the 
microtome.  Uncontrollable tissue damage resulted in the form of torn, ripped, and folded 
sections. Distal and midshaft regions proved to be the hardest regions to gather decent tissue 
sections from, most likely due to their smaller cross sectional areas.  This prevented analysis of 
a complete data set across all three regions from individual subjects.   
There are several limitations in the apoptosis detection technique.  Much concern lies in 
clearly distinguishing between apoptosis and necrosis since they are both forms of cell death. 
Detection of apoptosis was previously limited to morphology, but as more information about 
the cell death pathway is constantly being uncovered, other aspects of cell death can be 
analyzed.  TUNEL staining using the DNA fragmentation technique is used for detection in this 
current study.  While DNA fragmentation in necrosis is characterized by random, late, and 
usually single stranded breaks, opposite of apoptosis, DNA fragmentation may not necessarily 
signify apoptosis.  Fixation, embedding, and sectioning the tissue before staining may lead to 
fragmentation that results in false positive staining.  Ideally, the best approach for apoptosis 
identification should include a combination of techniques such as in situ end labeling and 
morphological criteria or ISEL and immunohistochemistry to ensure the most accurate results 
(Stadelmann and Lassmann 2000). 
In addition, the combination of the TUNEL stain and the methyl green counterstain 
resulted in problems identifying viable osteocytes during co-staining.  Our study performed 
separate TUNEL and methyl green stains on slides to more clearly distinguish viable osteocytes. 
However, overstaining may have occurred due to extra clumping and false positive staining.  
49 
 
Figuring out a way to effectively stain using both TUNEL and methyl green on one section would 
eliminate the need for double the amount of tissue sections as well as reduce the amount of 
overstaining.  Developing a consistent counting technique used during analysis proved 
challenging as well.  Rules were established to identify apoptotic osteocytes, viable osteocytes, 
and empty lacunae to ensure valid comparisons between data sets of each study. Only 
osteocytes with a clearly defined lacunar wall were counted and osteocytes outside of the 
plane were not included.  
Applications and Future Work  
 
Osteocyte apoptosis is fundamental to the life cycle of the skeleton.  During growth it is 
responsible for the expansion of the skeleton and during old age it plays a role in osteoporosis.   
The current study solely looked at unloaded bone samples to locate areas of apoptotic 
and viable osteocytes within hindlimbs.  The results of this study can be used as a control for 
future studies comparing other possible initiation factors of bone remodeling.  Since 
mechanical loading is known to induce apoptosis and subsequent bone remodeling, a future 
study on the regional variability of apoptotic osteocytes in loaded murine cortical bone would 
be a simple next step.  Similar considerations for future studies on bone remodeling stimuli 
could explore the role of apoptosis as a spatial and temporal marker in response to stimuli such 
as estrogen withdrawal or disuse. 
Studies of osteocyte apoptosis have been performed using mainly animal models.  
Hedgecock performed a quantitative analysis of bone remodeling factors and osteocyte 
apoptosis in rabbit hindlimbs (Hedgecock, Hadi et al. 2007).  Other research has mainly used 
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mice and rats to study apoptosis in vivo (Tomkinson, Gevers et al. 1998; Weinstein, Jilka et al. 
1998; Verborgt, Gibson et al. 2000; Noble, Peet et al. 2003).  Using different possibly larger 
animal models could potentially drive the research in a direction where it could be relatable to 
the human skeleton, which is the ultimate goal.  Until then, the observations from these studies 
can only be speculated in regards to the human skeleton. 
While TUNEL remains the standard for immunohistochemical detection techniques, 
other techniques could be explored to identify apoptosis.  The phenomenon itself is difficult 
enough to detect because it represents such a tiny fraction of the cell’s life span (Jilka, 
Weinstein et al. 2007).  Previously mentioned as a limitation, in situ nick end labeling has been 
attacked for its lack of specificity but is not the only apoptotic technique available to identify 
apoptotic cells.  Aside from being mistaken for necrotic cells, apoptotic cells may also be 
mistaken for oncotic cells which also undergo DNA fragmentation during cell death.  Newer, 
more specific methods that have been developed to detect single stranded DNA or caspace-3 
which is known to play a central role in the apoptotic process and has so far not been detected 
in oncosis (Van Cruchten and Van den Broek 2002).   
Apoptosis of bone cells has been the topic of much current research due to its role in 
the signaling pathway guiding bone turnover.  Since impairment or dysregulation of bone 
remodeling is the main cause of most skeletal diseases, apoptotic osteocytes may act as a 
therapeutic target for their treatment.  These skeletal disorders include post menopausal 
osteoporosis, osteoarthritis, and Paget’s disease.  Induction of apoptosis may be a potential 
therapeutic tool for treating these diseases (Hughes and Boyce 1997).  Drugs currently used 
today for the management of osteoporosis alter the frequency of apoptosis in bone cells such 
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as increasing osteoclast apoptosis or increasing osteoblast apoptosis in an attempt to correct 
the imbalance that leads to diminished bone mass (Weinstein and Manolagas 2000).  Also, 
identifying the selective pathways of apoptosis is important in finding potential targets for new 
therapeutic strategies (Hock, Krishnan et al. 2001).  Cell death by apoptosis plays a significant 
but complex role in bone physiology and pathology.   
Conclusion 
 
Identifying the location of apoptotic osteocytes within unloaded murine hindlimbs 
provides insight into a better understanding of the spatial and temporal relationship between 
dying osteocytes and bone remodeling.  This study examines the frequency of apoptotic 
osteocytes by quadrant and region within cross sections of bone and correlates their regional 
variability with possible factors that signal bone remodeling.  Quantitative evidence of a strong 
linear correlation between osteoctye apoptosis and gremlin expression specifically in the 
midshaft region offers a potential area for bone remodeling to be directed.  Further 
examination of the distribution of apoptotic osteocytes in bone undergoing super-physiologic 
loading conditions to induce bone turnover would provide more information on the 
relationship between apoptotic osteocytes and bone remodeling.  Understanding the role of 
apoptosis is essential in maintaining overall skeletal tissue homeostasis and developing 
treatments in the preventative care of skeletal pathologies.  
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Appendix A 
 
 
General linear models across all subjects by quadrant 
 
General Linear Model: TUNEL OD versus Quadrant  
 
Factor    Type   Levels  Values 
Quadrant  fixed       4  caudal, cranial, lateral, medial 
 
 
Analysis of Variance for TUNEL OD, using Adjusted SS for Tests 
 
Source    DF  Seq SS  Adj SS  Adj MS     F      P 
Quadrant   3    7219    7219    2406  0.43  0.736 
Error     24  135728  135728    5655 
Total     27  142948 
 
 
S = 75.2020   R-Sq = 5.05%   R-Sq(adj) = 0.00% 
 
 
Unusual Observations for TUNEL OD 
 
Obs  TUNEL OD      Fit  SE Fit  Residual  St Resid 
 15    62.073  205.996  28.424  -143.922     -2.07 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Quadrant  N   Mean  Grouping 
cranial   7  216.4  A 
lateral   7  206.0  A 
medial    7  198.3  A 
caudal    7  172.9  A 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable TUNEL OD 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
Quadrant   Lower  Center  Upper  ------+---------+---------+---------+ 
cranial   -67.35   43.50  154.4          (------------*-------------) 
lateral   -77.80   33.05  143.9        (-------------*-------------) 
medial    -85.48   25.37  136.2       (-------------*-------------) 
                                 ------+---------+---------+---------+ 
                                     -80         0        80       160 
 
 
Quadrant = cranial  subtracted from: 
 
Quadrant   Lower  Center   Upper  ------+---------+---------+---------+ 
lateral   -121.3  -10.45  100.40   (-------------*-------------) 
medial    -129.0  -18.13   92.72  (-------------*-------------) 
                                  ------+---------+---------+---------+ 
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                                      -80         0        80       160 
 
 
Quadrant = lateral  subtracted from: 
 
Quadrant   Lower  Center  Upper  ------+---------+---------+---------+ 
medial    -118.5  -7.685  103.2   (-------------*-------------) 
                                 ------+---------+---------+---------+ 
                                     -80         0        80       160 
 
 
Tukey Simultaneous Tests 
Response Variable TUNEL OD 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
cranial        43.50       40.20   1.0822    0.7035 
lateral        33.05       40.20   0.8223    0.8434 
medial         25.37       40.20   0.6311    0.9210 
 
 
Quadrant = cranial  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
lateral       -10.45       40.20  -0.2599    0.9937 
medial        -18.13       40.20  -0.4511    0.9688 
 
 
Quadrant = lateral  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
medial        -7.685       40.20  -0.1912    0.9975 
 
 
General Linear Model: Viable OD versus Quadrant  
 
Factor    Type   Levels  Values 
Quadrant  fixed       4  caudal, cranial, lateral, medial 
 
 
Analysis of Variance for Viable OD, using Adjusted SS for Tests 
 
Source    DF  Seq SS  Adj SS  Adj MS     F      P 
Quadrant   3   26519   26519    8840  0.62  0.606 
Error     24  339840  339840   14160 
Total     27  366360 
 
 
S = 118.996   R-Sq = 7.24%   R-Sq(adj) = 0.00% 
 
 
Unusual Observations for Viable OD 
 
Obs  Viable OD      Fit  SE Fit  Residual  St Resid 
  1    737.237  487.241  44.976   249.996      2.27 R 
  2    676.991  413.630  44.976   263.361      2.39 R 
 
R denotes an observation with a large standardized residual. 
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Grouping Information Using Tukey Method and 95.0% Confidence 
 
Quadrant  N   Mean  Grouping 
cranial   7  487.2  A 
medial    7  481.7  A 
lateral   7  436.9  A 
caudal    7  413.6  A 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable Viable OD 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
Quadrant   Lower  Center  Upper  -----+---------+---------+---------+- 
cranial   -101.8   73.61  249.0          (-----------*-----------) 
lateral   -152.1   23.31  198.7       (-----------*----------) 
medial    -107.4   68.04  243.4          (-----------*----------) 
                                 -----+---------+---------+---------+- 
                                   -150         0       150       300 
 
 
Quadrant = cranial  subtracted from: 
 
Quadrant   Lower  Center  Upper  -----+---------+---------+---------+- 
lateral   -225.7  -50.30  125.1  (-----------*----------) 
medial    -181.0   -5.57  169.8     (-----------*----------) 
                                 -----+---------+---------+---------+- 
                                   -150         0       150       300 
 
 
Quadrant = lateral  subtracted from: 
 
Quadrant   Lower  Center  Upper  -----+---------+---------+---------+- 
medial    -130.7   44.73  220.1        (-----------*-----------) 
                                 -----+---------+---------+---------+- 
                                   -150         0       150       300 
 
 
Tukey Simultaneous Tests 
Response Variable Viable OD 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
cranial        73.61       63.61   1.1573    0.6586 
lateral        23.31       63.61   0.3664    0.9828 
medial         68.04       63.61   1.0697    0.7108 
 
 
Quadrant = cranial  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
lateral       -50.30       63.61  -0.7908    0.8579 
medial         -5.57       63.61  -0.0875    0.9998 
 
 
Quadrant = lateral  subtracted from: 
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          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
medial         44.73       63.61   0.7033    0.8948 
 
General Linear Model: Total Lacunar D versus Quadrant  
 
Factor    Type   Levels  Values 
Quadrant  fixed       4  caudal, cranial, lateral, medial 
 
 
Analysis of Variance for Total Lacunar D, using Adjusted SS for Tests 
 
Source    DF  Seq SS  Adj SS  Adj MS     F      P 
Quadrant   3   40203   40203   13401  1.00  0.410 
Error     24  321905  321905   13413 
Total     27  362108 
 
 
S = 115.813   R-Sq = 11.10%   R-Sq(adj) = 0.00% 
 
 
Unusual Observations for Total Lacunar D 
 
         Total 
Obs  Lacunar D      Fit  SE Fit  Residual  St Resid 
 15    366.866  589.877  43.773  -223.011     -2.08 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Quadrant  N   Mean  Grouping 
medial    7  646.5  A 
cranial   7  629.1  A 
lateral   7  589.9  A 
caudal    7  548.3  A 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable Total Lacunar D 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
Quadrant   Lower  Center  Upper  ----+---------+---------+---------+-- 
cranial    -89.9   80.85  251.6          (----------*-----------) 
lateral   -129.1   41.60  212.3       (-----------*----------) 
medial     -72.5   98.25  269.0           (-----------*----------) 
                                 ----+---------+---------+---------+-- 
                                  -150         0       150       300 
 
 
Quadrant = cranial  subtracted from: 
 
Quadrant   Lower  Center  Upper  ----+---------+---------+---------+-- 
lateral   -210.0  -39.25  131.5  (----------*-----------) 
medial    -153.3   17.40  188.1      (----------*-----------) 
                                 ----+---------+---------+---------+-- 
                                  -150         0       150       300 
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Quadrant = lateral  subtracted from: 
 
Quadrant   Lower  Center  Upper  ----+---------+---------+---------+-- 
medial    -114.1   56.65  227.4        (-----------*----------) 
                                 ----+---------+---------+---------+-- 
                                  -150         0       150       300 
 
 
Tukey Simultaneous Tests 
Response Variable Total Lacunar D 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
cranial        80.85       61.90   1.3061    0.5681 
lateral        41.60       61.90   0.6721    0.9066 
medial         98.25       61.90   1.5871    0.4045 
 
 
Quadrant = cranial  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
lateral       -39.25       61.90  -0.6340    0.9200 
medial         17.40       61.90   0.2810    0.9921 
 
 
Quadrant = lateral  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
medial         56.65       61.90   0.9151    0.7971 
 
General Linear Model: TUNEL ratio versus Quadrant  
 
Factor    Type   Levels  Values 
Quadrant  fixed       4  caudal, cranial, lateral, medial 
 
 
Analysis of Variance for TUNEL ratio, using Adjusted SS for Tests 
 
Source    DF   Seq SS   Adj SS   Adj MS     F      P 
Quadrant   3  0.01188  0.01188  0.00396  0.38  0.769 
Error     24  0.25093  0.25093  0.01046 
Total     27  0.26281 
 
 
S = 0.102251   R-Sq = 4.52%   R-Sq(adj) = 0.00% 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Quadrant  N  Mean  Grouping 
cranial   7   0.4  A 
lateral   7   0.4  A 
caudal    7   0.3  A 
medial    7   0.3  A 
 
Means that do not share a letter are significantly different. 
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Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable TUNEL ratio 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
Quadrant    Lower     Center   Upper  -------+---------+---------+--------- 
cranial   -0.1071   0.043658  0.1944          (------------*-----------) 
lateral   -0.1214   0.029306  0.1800         (-----------*------------) 
medial    -0.1571  -0.006384  0.1443      (-----------*------------) 
                                      -------+---------+---------+--------- 
                                          -0.12      0.00      0.12 
 
 
Quadrant = cranial  subtracted from: 
 
Quadrant    Lower    Center   Upper  -------+---------+---------+--------- 
lateral   -0.1651  -0.01435  0.1364     (------------*-----------) 
medial    -0.2008  -0.05004  0.1007  (------------*-----------) 
                                     -------+---------+---------+--------- 
                                         -0.12      0.00      0.12 
 
 
Quadrant = lateral  subtracted from: 
 
Quadrant    Lower    Center   Upper  -------+---------+---------+--------- 
medial    -0.1864  -0.03569  0.1150   (------------*------------) 
                                     -------+---------+---------+--------- 
                                         -0.12      0.00      0.12 
 
 
Tukey Simultaneous Tests 
Response Variable TUNEL ratio 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
cranial     0.043658     0.05466   0.7988    0.8543 
lateral     0.029306     0.05466   0.5362    0.9493 
medial     -0.006384     0.05466  -0.1168    0.9994 
 
 
Quadrant = cranial  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
lateral     -0.01435     0.05466  -0.2626    0.9935 
medial      -0.05004     0.05466  -0.9156    0.7968 
 
 
Quadrant = lateral  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
medial      -0.03569     0.05466  -0.6530    0.9135 
 
 
General Linear Model: Viable ratio versus Quadrant  
 
Factor    Type   Levels  Values 
Quadrant  fixed       4  caudal, cranial, lateral, medial 
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Analysis of Variance for Viable ratio, using Adjusted SS for Tests 
 
Source    DF    Seq SS    Adj SS    Adj MS     F      P 
Quadrant   3  0.000654  0.000654  0.000218  0.05  0.987 
Error     24  0.115500  0.115500  0.004812 
Total     27  0.116153 
 
 
S = 0.0693720   R-Sq = 0.56%   R-Sq(adj) = 0.00% 
 
 
Unusual Observations for Viable ratio 
 
Obs  Viable ratio       Fit    SE Fit   Residual  St Resid 
 11      0.516129  0.684375  0.026220  -0.168246     -2.62 R 
 12      0.521739  0.685869  0.026220  -0.164130     -2.56 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Quadrant  N  Mean  Grouping 
cranial   7   0.7  A 
medial    7   0.7  A 
lateral   7   0.7  A 
caudal    7   0.7  A 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable Viable ratio 
All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
Quadrant     Lower    Center   Upper  -----+---------+---------+---------+- 
cranial   -0.08880  0.013456  0.1157    (--------------*--------------) 
lateral   -0.09495  0.007313  0.1096   (--------------*--------------) 
medial    -0.09345  0.008808  0.1111    (-------------*--------------) 
                                      -----+---------+---------+---------+- 
                                        -0.070     0.000     0.070     0.140 
 
 
Quadrant = cranial  subtracted from: 
 
Quadrant    Lower     Center    Upper  -----+---------+---------+---------+- 
lateral   -0.1084  -0.006143  0.09612  (-------------*--------------) 
medial    -0.1069  -0.004648  0.09761  (-------------*--------------) 
                                       -----+---------+---------+---------+- 
                                         -0.070     0.000     0.070     0.140 
 
 
Quadrant = lateral  subtracted from: 
 
Quadrant    Lower    Center   Upper  -----+---------+---------+---------+- 
medial    -0.1008  0.001495  0.1038   (-------------*--------------) 
                                     -----+---------+---------+---------+- 
                                       -0.070     0.000     0.070     0.140 
 
 
Tukey Simultaneous Tests 
Response Variable Viable ratio 
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All Pairwise Comparisons among Levels of Quadrant 
Quadrant = caudal  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
cranial     0.013456     0.03708   0.3629    0.9833 
lateral     0.007313     0.03708   0.1972    0.9972 
medial      0.008808     0.03708   0.2375    0.9952 
 
 
Quadrant = cranial  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
lateral    -0.006143     0.03708  -0.1657    0.9983 
medial     -0.004648     0.03708  -0.1254    0.9993 
 
 
Quadrant = lateral  subtracted from: 
 
          Difference       SE of           Adjusted 
Quadrant    of Means  Difference  T-Value   P-Value 
medial      0.001495     0.03708  0.04031     1.000 
 
 
General linear models across all subjects by region 
 
General Linear Model: TUNEL OD versus Region  
 
Factor  Type   Levels  Values 
Region  fixed       3  distal, midshaft, proximal 
 
 
Analysis of Variance for TUNEL OD, using Adjusted SS for Tests 
 
Source  DF  Seq SS  Adj SS  Adj MS     F      P 
Region   2   60954   60954   30477  9.29  0.001 
Error   25   81993   81993    3280 
Total   27  142948 
 
 
S = 57.2690   R-Sq = 42.64%   R-Sq(adj) = 38.05% 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Region     N   Mean  Grouping 
midshaft   8  271.1  A 
distal     8  180.9    B 
proximal  12  161.6    B 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable TUNEL OD 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
Region     Lower  Center   Upper  -------+---------+---------+--------- 
midshaft   18.90   90.17  161.44                     (------*------) 
proximal  -84.37  -19.31   45.75           (-----*------) 
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                                  -------+---------+---------+--------- 
                                      -100         0       100 
 
 
Region = midshaft  subtracted from: 
 
Region     Lower  Center   Upper  -------+---------+---------+--------- 
proximal  -174.5  -109.5  -44.42  (-----*------) 
                                  -------+---------+---------+--------- 
                                      -100         0       100 
 
 
Tukey Simultaneous Tests 
Response Variable TUNEL OD 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
midshaft       90.17       28.63   3.1489    0.0113 
proximal      -19.31       26.14  -0.7387    0.7431 
 
 
Region = midshaft  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
proximal      -109.5       26.14   -4.188    0.0009 
 
General Linear Model: Viable OD versus Region  
 
Factor  Type   Levels  Values 
Region  fixed       3  distal, midshaft, proximal 
 
 
Analysis of Variance for Viable OD, using Adjusted SS for Tests 
 
Source  DF  Seq SS  Adj SS  Adj MS      F      P 
Region   2  191212  191212   95606  13.65  0.000 
Error   25  175148  175148    7006 
Total   27  366360 
 
 
S = 83.7013   R-Sq = 52.19%   R-Sq(adj) = 48.37% 
 
 
Unusual Observations for Viable OD 
 
Obs  Viable OD      Fit  SE Fit  Residual  St Resid 
 22    393.548  585.506  29.593  -191.958     -2.45 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Region     N   Mean  Grouping 
midshaft   8  585.5  A 
proximal  12  404.2    B 
distal     8  400.2    B 
 
Means that do not share a letter are significantly different. 
65 
 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable Viable OD 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
Region     Lower   Center   Upper  -------+---------+---------+--------- 
midshaft   81.13  185.294  289.46                        (------*-----) 
proximal  -91.08    4.007   99.10             (-----*-----) 
                                   -------+---------+---------+--------- 
                                       -160         0       160 
 
 
Region = midshaft  subtracted from: 
 
Region     Lower  Center   Upper  -------+---------+---------+--------- 
proximal  -276.4  -181.3  -86.20  (-----*-----) 
                                  -------+---------+---------+--------- 
                                      -160         0       160 
 
 
Tukey Simultaneous Tests 
Response Variable Viable OD 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
midshaft     185.294       41.85   4.4275    0.0005 
proximal       4.007       38.20   0.1049    0.9940 
 
 
Region = midshaft  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
proximal      -181.3       38.20   -4.745    0.0002 
 
General Linear Model: Total Lacunar D versus Region  
 
Factor  Type   Levels  Values 
Region  fixed       3  distal, midshaft, proximal 
 
 
Analysis of Variance for Total Lacunar D, using Adjusted SS for Tests 
 
Source  DF  Seq SS  Adj SS  Adj MS     F      P 
Region   2  122099  122099   61049  6.36  0.006 
Error   25  240009  240009    9600 
Total   27  362108 
 
 
S = 97.9815   R-Sq = 33.72%   R-Sq(adj) = 28.42% 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Region     N   Mean  Grouping 
midshaft   8  704.9  A 
distal     8  585.6  A B 
proximal  12  547.7    B 
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Means that do not share a letter are significantly different. 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable Total Lacunar D 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
Region     Lower  Center   Upper  --------+---------+---------+-------- 
midshaft    -2.6  119.29  241.23                    (-------*-------) 
proximal  -149.2  -37.85   73.47          (------*-------) 
                                  --------+---------+---------+-------- 
                                       -150         0       150 
 
 
Region = midshaft  subtracted from: 
 
Region     Lower  Center   Upper  --------+---------+---------+-------- 
proximal  -268.5  -157.1  -45.82  (-------*------) 
                                  --------+---------+---------+-------- 
                                       -150         0       150 
 
 
Tukey Simultaneous Tests 
Response Variable Total Lacunar D 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
midshaft      119.29       48.99   2.4350    0.0563 
proximal      -37.85       44.72  -0.8463    0.6783 
 
 
Region = midshaft  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
proximal      -157.1       44.72   -3.514    0.0047 
 
  
General Linear Model: TUNEL ratio versus Region  
 
Factor  Type   Levels  Values 
Region  fixed       3  distal, midshaft, proximal 
 
 
Analysis of Variance for TUNEL ratio, using Adjusted SS for Tests 
 
Source  DF    Seq SS    Adj SS    Adj MS     F      P 
Region   2  0.068793  0.068793  0.034396  4.43  0.023 
Error   25  0.194015  0.194015  0.007761 
Total   27  0.262808 
 
 
S = 0.0880943   R-Sq = 26.18%   R-Sq(adj) = 20.27% 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Region     N  Mean  Grouping 
midshaft   8   0.4  A 
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distal     8   0.3  A B 
proximal  12   0.3    B 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable TUNEL ratio 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
Region      Lower    Center    Upper  --------+---------+---------+-------- 
midshaft  -0.0264   0.08321  0.19284                  (--------*--------) 
proximal  -0.1359  -0.03581  0.06427         (-------*-------) 
                                      --------+---------+---------+-------- 
                                           -0.12      0.00      0.12 
 
 
Region = midshaft  subtracted from: 
 
Region      Lower   Center     Upper  --------+---------+---------+-------- 
proximal  -0.2191  -0.1190  -0.01894  (-------*-------) 
                                      --------+---------+---------+-------- 
                                           -0.12      0.00      0.12 
 
 
Tukey Simultaneous Tests 
Response Variable TUNEL ratio 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
midshaft     0.08321     0.04405   1.8891    0.1627 
proximal    -0.03581     0.04021  -0.8907    0.6510 
 
 
Region = midshaft  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
proximal     -0.1190     0.04021   -2.960    0.0176 
 
  
General Linear Model: Viable ratio versus Region  
 
Factor  Type   Levels  Values 
Region  fixed       3  distal, midshaft, proximal 
 
 
Analysis of Variance for Viable ratio, using Adjusted SS for Tests 
 
Source  DF    Seq SS    Adj SS    Adj MS     F      P 
Region   2  0.047830  0.047830  0.023915  8.75  0.001 
Error   25  0.068323  0.068323  0.002733 
Total   27  0.116153 
 
 
S = 0.0522774   R-Sq = 41.18%   R-Sq(adj) = 36.47% 
 
 
Unusual Observations for Viable ratio 
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Obs  Viable ratio       Fit    SE Fit   Residual  St Resid 
 11      0.516129  0.620943  0.018483  -0.104814     -2.14 R 
 12      0.521739  0.620943  0.018483  -0.099204     -2.03 R 
 28      0.739726  0.620943  0.018483   0.118783      2.43 R 
 
R denotes an observation with a large standardized residual. 
 
 
Grouping Information Using Tukey Method and 95.0% Confidence 
 
Region     N  Mean  Grouping 
midshaft   8   0.7  A 
proximal  12   0.7  A 
distal     8   0.6    B 
 
Means that do not share a letter are significantly different. 
 
 
Tukey 95.0% Simultaneous Confidence Intervals 
Response Variable Viable ratio 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
Region      Lower   Center   Upper   --+---------+---------+---------+---- 
midshaft  0.03796  0.10302  0.1681                    (---------*--------) 
proximal  0.02013  0.07952  0.1389                  (-------*--------) 
                                     --+---------+---------+---------+---- 
                                    -0.070     0.000     0.070     0.140 
 
 
Region = midshaft  subtracted from: 
 
Region       Lower    Center    Upper   --+---------+---------+---------+---- 
proximal  -0.08289  -0.02350  0.03589   (--------*-------) 
                                        --+---------+---------+---------+---- 
                                       -0.070     0.000     0.070     0.140 
 
 
Tukey Simultaneous Tests 
Response Variable Viable ratio 
All Pairwise Comparisons among Levels of Region 
Region = distal  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
midshaft     0.10302     0.02614    3.941    0.0016 
proximal     0.07952     0.02386    3.333    0.0073 
 
 
Region = midshaft  subtracted from: 
 
          Difference       SE of           Adjusted 
Region      of Means  Difference  T-Value   P-Value 
proximal    -0.02350     0.02386  -0.9848    0.5930 
 
 
 
 
